Levosimendan in intensive care and emergency medicine: literature update and expert recommendations for optimal efficacy and safety

The inodilator levosimendan, in clinical use for over two decades, has been the subject of extensive clinical and experimental evaluation in various clinical settings beyond its principal indication in the management of acutely decompensated chronic heart failure. Critical care and emergency medicin...

Descripción completa

Detalles Bibliográficos
Autores principales: Girardis, M., Bettex, D., Bojan, M., Demponeras, C., Fruhwald, S., Gál, J., Groesdonk, H. V., Guarracino, F., Guerrero-Orriach, J. L., Heringlake, M., Herpain, A., Heunks, L., Jin, J., Kindgen-Milles, D., Mauriat, P., Michels, G., Psallida, V., Rich, S., Ricksten, S-E, Rudiger, A., Siegemund, M., Toller, W., Treskatsch, S., Župan, Ž., Pollesello, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785009/
https://www.ncbi.nlm.nih.gov/pubmed/37386589
http://dx.doi.org/10.1186/s44158-021-00030-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785009/
https://www.ncbi.nlm.nih.gov/pubmed/37386589
http://dx.doi.org/10.1186/s44158-021-00030-7

Ejemplares similares